Gastrointestinal lumenal drugs and toxins

Gastrointestinal lumenal drugs and toxins refers to the collective group of exogenous substances, including pharmaceutical agents and environmental poisons, that reside within the lumen of the stomach and intestines following ingestion (DrugBank, 2024). While not a biological protein, receptor, or enzyme, this category is classified as a pharmacological target for adsorbents like activated charcoal in clinical toxicology (StatPearls, 2023). The primary function of targeting these substances is to prevent their absorption into the systemic circulation, thereby reducing the risk of toxicity or overdose (NIH, 2022). Drugs interact with this target through non-specific physical adsorption, where the high surface area of the adsorbent traps the toxins within its structure (PubChem, 2024). This target is highly heterogeneous, encompassing a vast range of chemical structures and molecular weights. Consequently, therapeutic interventions are generally non-selective and are primarily utilized in emergency medical settings for gastric decontamination (StatPearls, 2023). A significant challenge in targeting this entity is the potential for the adsorbent to bind essential nutrients or other therapeutic medications, leading to decreased efficacy of co-administered drugs (DrugBank, 2024).

Other names

Gastrointestinal lumenal toxinsIntestinal drugs and toxinsLuminal poisonsGastrointestinal lumenal drugs

Physical adsorption and sequestration of substances within the gastrointestinal lumen to prevent systemic absorption (StatPearls, 2023; DrugBank, 2024).